Cargando…
Hydroxychloroquine for early treatment of COVID-19: Absence of evidence is different from evidence of absence
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271171/ https://www.ncbi.nlm.nih.gov/pubmed/35844777 http://dx.doi.org/10.1016/j.lana.2022.100314 |
| _version_ | 1784744621304184832 |
|---|---|
| author | Furlan, Leonardo |
| author_facet | Furlan, Leonardo |
| author_sort | Furlan, Leonardo |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9271171 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92711712022-07-11 Hydroxychloroquine for early treatment of COVID-19: Absence of evidence is different from evidence of absence Furlan, Leonardo Lancet Reg Health Am Correspondence Elsevier 2022-07-10 /pmc/articles/PMC9271171/ /pubmed/35844777 http://dx.doi.org/10.1016/j.lana.2022.100314 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Correspondence Furlan, Leonardo Hydroxychloroquine for early treatment of COVID-19: Absence of evidence is different from evidence of absence |
| title | Hydroxychloroquine for early treatment of COVID-19: Absence of evidence is different from evidence of absence |
| title_full | Hydroxychloroquine for early treatment of COVID-19: Absence of evidence is different from evidence of absence |
| title_fullStr | Hydroxychloroquine for early treatment of COVID-19: Absence of evidence is different from evidence of absence |
| title_full_unstemmed | Hydroxychloroquine for early treatment of COVID-19: Absence of evidence is different from evidence of absence |
| title_short | Hydroxychloroquine for early treatment of COVID-19: Absence of evidence is different from evidence of absence |
| title_sort | hydroxychloroquine for early treatment of covid-19: absence of evidence is different from evidence of absence |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271171/ https://www.ncbi.nlm.nih.gov/pubmed/35844777 http://dx.doi.org/10.1016/j.lana.2022.100314 |
| work_keys_str_mv | AT furlanleonardo hydroxychloroquineforearlytreatmentofcovid19absenceofevidenceisdifferentfromevidenceofabsence |